CLB Stock Recent News

Core Laboratories (CLB) expects Reservoir Description revenues of $86.5-$89.5 million and Production Enhancement revenues of $44.5-$47.5 million for the third quarter of 2024.

Core Laboratories (CLB) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.21 per share a year ago.

Core Laboratories (CLB) is expected to report higher revenues from the year-ago period's level. It is also likely to have incurred higher operating expenses.

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript

Core Laboratories (CLB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

While the top- and bottom-line numbers for Core Laboratories (CLB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.